About Veru Inc.
Veru is a late-stage biopharma developing obesity and cardiometabolic drugs. Micro-cap penny stock, highly speculative with binary clinical trial catalysts. No dividend. Thin options liquidity and wide bid-ask spreads make CSP selling impractical; extreme gap risk on trial data readouts.
Biotechnology